Treatment with romosozumab led to improvements in bone microarchitecture among postmenopausal women with osteoporosis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback